Last reviewed · How we verify
NCT07095322: WISH
Investigating the Feasibility and Acceptability of Co-created Intervention to Improve Women's Participation in Muscle-strengthening Exercises
NA trial testing Strength Education Session in Physical Activities in 31 participants. Completed in 7 July 2025.
7 July 2025
Quick facts
| Lead sponsor | University of Glasgow |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 31 |
| Start date | 4 December 2024 |
| Primary completion | 7 July 2025 |
| Estimated completion | 7 July 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Strength Education Session
- Gym Membership
- Group Exercise Session
- Training Log
- Support group
Conditions studied
- Physical Activities — all drugs for Physical Activities →
- Exercise — all drugs for Exercise →
- Muscular Strength — all drugs for Muscular Strength →
- Healthy Women — all drugs for Healthy Women →
Sponsor
University of Glasgow
Who can join
Adults 18 to 45, female only, with Physical Activities or Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will utilise the Randomised Controlled Trial (RCT) design. Following completion of the baseline measurements, participants will be randomly assigned to either the control group or the intervention group. Control Group Control group will be asked to maintain normal activity levels for 24 weeks. On completion of the 24 weeks, 12-week University of Glasgow Sports gym membership will be given. Intervention Group The overall aim of the intervention is for participants to participate in muscle strengthening exercises, of choice, two days a week. These exercises can include weight machine, resistance band and body weight resistance exercises, alongside strength training classes such as yoga and body pump. The intervention will begin with weekly education sessions over the first 4 weeks, to help make sure participants are confident and competent in performing exercises. Participants will be given a gym membership for the 12-week intervention period and asked to log all muscle strengthening exercises that participants participate in. Throughout the intervention, participants will receive weekly support reminder messages via WhatsApp from the research team, and researcher will also set up a social support group on WhatsApp for the participants. Weekly group-based exercise sessions with the researcher will also be offered to the participants; these will be optional. The following data will be collected from all participants. All measures will be collected at baseline, mid-intervention measurement (week 6), post-intervention (week 12), and follow-up (week 24) except for follow-up interview and participants will be given an Amazon voucher worth £25 for every measurement period attend. Each test/measure is detailed further below. During baseline measurement, researcher will ask the participants on their age, postcode, ethnic background, work situation, highest qualification completed, marital status, caregiver or not and the rating of health. Following this researcher will measure participants' body composition where the weight, height, fat mass, fat percentages, muscle mass and muscle size will be recorded. Muscular strength will be measured using three strength tests which are the grip strength test, back strength test and maximal voluntary contraction. Participants will be shown how to perform the test by the research team before performing it. Participants will be asked to do each test 3 times with rest in between each attempt. The body composition and strength test will be conducted again in week 6, 12 and 24. Intervention group will be involved in a follow-up interview during the measurement visit on week 12 and 24 to discuss the experiences and feedback on the intervention with the researchers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07095322
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Physical Activities
Currently open trials in the same condition.
- NCT07430943 — Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation · NA · recruiting
- NCT07442955 — Impact of Digital Muscle Strength on Activity in Tech-Addicted University Students · active not recruiting
- NCT07346300 — We-Move With Windy: Gross Motor Development for Early Childhood · NA · recruiting
- NCT07343700 — Community Expecting: Exercise During Pregnancy · NA · recruiting
- NCT07379970 — Effects of Wearable Device Functions and Health Coaching on Device-measured Movement Behaviours and Cardiometabolic Risk · NA · recruiting
Other University of Glasgow trials
Trials by the same sponsor.
- NCT07500792 — Effect of Early Time-Restricted Eating on Appetite, Appetite-Regulatory Hormones and Energy Intake · NA · not yet recruiting
- NCT07388121 — The Effect of Vitamin C Supplementation on Gut Microbiota Composition and Function in Healthy Adults · NA · recruiting
- NCT07130513 — Investigating the Feasibility of Krill Oil Intervention to Improve Muscle Function in Adults With Long-term Conditions · NA · recruiting
- NCT06895837 — Effect of Exercise on Appetite in Response to Meals During Energy Restriction · NA · recruiting
- NCT06939244 — Investigating the Effects of Krill Oil on the Recovery From Muscle Damaging Exercise: a Randomised Controlled Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07095322 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Glasgow
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07095322.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing